Inhibiting alternative pathway complement activation by targeting the factor d exosite.
Katschke, K.J., Wu, P., Ganesan, R., Kelley, R.F., Mathieu, M.A., Hass, P.E., Murray, J., Kirchhofer, D., Wiesmann, C., van Lookeren Campagne, M.(2012) J Biol Chem 287: 12886-12892
- PubMed: 22362762 
- DOI: 10.1074/jbc.M112.345082
- Primary Citation of Related Structures:  
4D9Q, 4D9R - PubMed Abstract: 
By virtue of its amplifying property, the alternative complement pathway has been implicated in a number of inflammatory diseases and constitutes an attractive therapeutic target. An anti-factor D Fab fragment (AFD) was generated to inhibit the alternati ...